MEDICATION ACCESS AND TRAINING EXPANSION (MATE) ACT
Section 1263 of the FY 2023 Omnibus Appropriations bill was enacted by Congress on December 29, 2022, and requires prescribers of controlled substances to complete eight hours of one-time training on safe controlled substance prescribing to receive or renew their registration with the U.S. Drug Enforcement Administration (DEA). Within the bill was statutory language taken from the Medication Access and Training Expansion Act (or MATE Act). The MATE Act imposes a new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance use disorders prior to receiving or renewing a DEA registration. To assist in complying with the new requirements, PAMED has addressed common questions members may have.
Does this new federal training requirement affect me?
All DEA-registered prescribers, with the exception of those that are solely veterinarians, are subject to the new training requirement.
How will I be required to report that I’ve satisfied the new requirement?
Beginning on June 27, 2023, prescribers will be required to check a box on their online DEA registration form, regardless of whether it is an initial application or renewal, affirming they have completed 8 hours of training on safe controlled substance prescribing.
